Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis.
<h4>Background</h4>Leprosy is a disease of the skin and peripheral nervous system caused by the obligate intracellular bacterium Mycobacterium leprae. The clinical presentations of leprosy are spectral, with the severity of disease determined by the balance between the cellular and humor...
Enregistré dans:
Auteurs principaux: | , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b1ed724d990d4b8d92faa1b1ca4eff0b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
id |
oai:doaj.org-article:b1ed724d990d4b8d92faa1b1ca4eff0b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b1ed724d990d4b8d92faa1b1ca4eff0b2021-11-18T09:13:04ZSerum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis.1935-27271935-273510.1371/journal.pntd.0001303https://doaj.org/article/b1ed724d990d4b8d92faa1b1ca4eff0b2011-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21909445/pdf/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Leprosy is a disease of the skin and peripheral nervous system caused by the obligate intracellular bacterium Mycobacterium leprae. The clinical presentations of leprosy are spectral, with the severity of disease determined by the balance between the cellular and humoral immune response of the host. The exact mechanisms that facilitate disease susceptibility, onset and progression to certain clinical phenotypes are presently unclear. Various studies have examined lipid metabolism in leprosy, but there has been limited work using whole metabolite profiles to distinguish the clinical forms of leprosy.<h4>Methodology and principal findings</h4>In this study we adopted a metabolomics approach using high mass accuracy ultrahigh pressure liquid chromatography mass spectrometry (UPLC-MS) to investigate the circulatory biomarkers in newly diagnosed untreated leprosy patients. Sera from patients having bacterial indices (BI) below 1 or above 4 were selected, subjected to UPLC-MS, and then analyzed for biomarkers which distinguish the polar presentations of leprosy. We found significant increases in the abundance of certain polyunsaturated fatty acids (PUFAs) and phospholipids in the high-BI patients, when contrasted with the levels in the low-BI patients. In particular, the median values of arachidonic acid (2-fold increase), eicosapentaenoic acid (2.6-fold increase) and docosahexaenoic acid (1.6-fold increase) were found to be greater in the high-BI patients.<h4>Significance</h4>Eicosapentaenoic acid and docosahexaenoic acid are known to exert anti-inflammatory properties, while arachidonic acid has been reported to have both pro- and anti-inflammatory activities. The observed increase in the levels of several lipids in high-BI patients may provide novel clues regarding the biological pathways involved in the immunomodulation of leprosy. Furthermore, these results may lead to the discovery of biomarkers that can be used to investigate susceptibility to infection, facilitate early diagnosis and monitor the progression of disease.Reem Al-MubarakJason Vander HeidenCorey D BroecklingMarivic BalagonPatrick J BrennanVaralakshmi D VissaPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 5, Iss 9, p e1303 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Reem Al-Mubarak Jason Vander Heiden Corey D Broeckling Marivic Balagon Patrick J Brennan Varalakshmi D Vissa Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
description |
<h4>Background</h4>Leprosy is a disease of the skin and peripheral nervous system caused by the obligate intracellular bacterium Mycobacterium leprae. The clinical presentations of leprosy are spectral, with the severity of disease determined by the balance between the cellular and humoral immune response of the host. The exact mechanisms that facilitate disease susceptibility, onset and progression to certain clinical phenotypes are presently unclear. Various studies have examined lipid metabolism in leprosy, but there has been limited work using whole metabolite profiles to distinguish the clinical forms of leprosy.<h4>Methodology and principal findings</h4>In this study we adopted a metabolomics approach using high mass accuracy ultrahigh pressure liquid chromatography mass spectrometry (UPLC-MS) to investigate the circulatory biomarkers in newly diagnosed untreated leprosy patients. Sera from patients having bacterial indices (BI) below 1 or above 4 were selected, subjected to UPLC-MS, and then analyzed for biomarkers which distinguish the polar presentations of leprosy. We found significant increases in the abundance of certain polyunsaturated fatty acids (PUFAs) and phospholipids in the high-BI patients, when contrasted with the levels in the low-BI patients. In particular, the median values of arachidonic acid (2-fold increase), eicosapentaenoic acid (2.6-fold increase) and docosahexaenoic acid (1.6-fold increase) were found to be greater in the high-BI patients.<h4>Significance</h4>Eicosapentaenoic acid and docosahexaenoic acid are known to exert anti-inflammatory properties, while arachidonic acid has been reported to have both pro- and anti-inflammatory activities. The observed increase in the levels of several lipids in high-BI patients may provide novel clues regarding the biological pathways involved in the immunomodulation of leprosy. Furthermore, these results may lead to the discovery of biomarkers that can be used to investigate susceptibility to infection, facilitate early diagnosis and monitor the progression of disease. |
format |
article |
author |
Reem Al-Mubarak Jason Vander Heiden Corey D Broeckling Marivic Balagon Patrick J Brennan Varalakshmi D Vissa |
author_facet |
Reem Al-Mubarak Jason Vander Heiden Corey D Broeckling Marivic Balagon Patrick J Brennan Varalakshmi D Vissa |
author_sort |
Reem Al-Mubarak |
title |
Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
title_short |
Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
title_full |
Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
title_fullStr |
Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
title_full_unstemmed |
Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
title_sort |
serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/b1ed724d990d4b8d92faa1b1ca4eff0b |
work_keys_str_mv |
AT reemalmubarak serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis AT jasonvanderheiden serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis AT coreydbroeckling serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis AT marivicbalagon serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis AT patrickjbrennan serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis AT varalakshmidvissa serummetabolomicsrevealshigherlevelsofpolyunsaturatedfattyacidsinlepromatousleprosypotentialmarkersforsusceptibilityandpathogenesis |
_version_ |
1718420985402621952 |